PERARD Laurent

Dernières publications

• Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: A multicenter study of 132 patients.; Semin Arthritis Rheum; Groupe Sarcoïdose Francophone; 2017 Mar 8; Jamilloux Y, Cohen-Aubart F, Chapelon-Abric C, Maucort-Boulch D, Marquet A, Pérard L, Bouillet L, Deroux A, Abad S, Bielefeld P, Bouvry D, André M, Noel N, Bienvenu B, Proux A, Vukusic S, Bodaghi B, Sarrot-Reynauld F, Iwaz J, Amoura Z, Broussolle C, Cacoub P, Saadoun D, Valeyre D, Sève P
• Clinical Presentation, Diagnosis, and Bacterial Epidemiology of Peritoneal Tuberculosis in Two University Hospitals in France.; Infect Dis Ther; 2016 Jun 13; Cavalli Z, Ader F, Valour F, Saison J, Boussel L, Dumitrescu O, Perpoint T, Chidiac C, May T, Ferry T; Perard L
• Efficacy of Anti-TNFα in Severe and Refractory Neuro-Behcet Disease: An Observational Study.; Medicine (Baltimore); 2016 Jun;95(23); Desbois AC, Addimanda O, Bertrand A, Deroux A, Pérard L
• Infliximab Versus Adalimumab in the Treatment of Refractory Inflammatory Uveitis: A Multicenter Study From the French Uveitis Network.; French Uveitis Network. Arthritis Rheumatol; 2016 Jun;68(6); Vallet H, Seve P, Biard L, Baptiste Fraison J, Bielefeld P, Perard L
• Clinical features and prognostic factors of spinal cord sarcoidosis: a multicenter observational study of 20 BIOPSY-PROVEN patients.; J Neurol. 2016 May;263(5):981-90. Durel CA; Marignier R, Maucort-Boulch D, Iwaz J, Berthoux E, Ruivard M, André M, Le Guenno G, Pérard L
• Quality of life in systemic lupus erythematosus: description in a cohort of French patients and association with blood hydroxychloroquine levels.; Lupus. 2016 Feb 13; Jolly M, Galicier L, Aumaître O, Francès C, Le Guern V, Lioté F, Smail A, Limal N, Perard L
• A Comparative Study of Characteristics and Outcomes of Patients with Proved and Suggested Sarcoid Uveitis Occurring after Ophthalmic Procedure.; J Ophthalmol. 2018 Oct 18;2018:2954546 ; Jamilloux Y, Taleb A, De Parisot A, Pérard L, Burillon C, Broussolle C, Kodjikian L, Sève P.
• BTNL2 gene polymorphism and sarcoid uveitis.; Br J Ophthalmol. 2019 Mar 14. pii: bjophthalmol-2018-312949; Chaperon M, Pacheco Y, Maucort-Boulch D, Iwaz J, Perard L, Broussolle C, Jamilloux Y, Burillon C, Kodjikian L, Calender A, Seve P
• Ethnicity and association with ocular, systemic manifestations and prognosis in 194 patients with sarcoid uveitis ; Graefes Arch Clin Exp Ophthalmol. 2019 Jul 13; Coulon C, Kodjikian L, Rochepeau C, Perard L, Jardel S, Burillon C, Broussolle C, Jamilloux Y, Seve P.
• Reducing the initial number of rituximab maintenance-therapy infusions for ANCA-associated vasculitides: randomized-trial post-hoc analysis ;Rheumatology (Oxford). 2020 Mar 9:kez621. doi: 10.1093/rheumatology/kez621. Online ahead of print.PMID: 3215026; Charles P, Dechartres A, Terrier B, Cohen P, Faguer S, Huart A, Hamidou M, Agard C, Bonnotte B, Samson M, Karras A, Jourde-Chiche N, Lifermann F, Gobert P, Hanrotel-Saliou C, Godmer P, Martin-Silva N, Pugnet G, Matignon M, Aumaitre O, Viallard JF, Maurier F, Meaux-Ruault N, Rivière S, Sibilia J, Puéchal X, Mouthon L, Guillevin L; French Vasculitis Study Group.
• Evaluating the cost-consequence of a standardized strategy for the etiological diagnosis of uveitis (ULISSE study) ; ULISSE group.PLoS One. 2020 Feb 14;15(2):e0228918. doi: 10.1371/journal.pone.0228918. eCollection 2020.PMID: 32059021; de Parisot A, Jamilloux Y, Kodjikian L, Errera MH, Sedira N, Heron E, Pérard L, Cornut PL, Schneider C, Rivière S, Ollé P, Pugnet G, Cathébras P, Manoli P, Bodaghi B, Saadoun D, Baillif S, Tieulie N, André M, Chiambaretta F, Bonin N, Bielefeld P, Bron A, Mouriaux F, Bienvenu B, Amamra N, Guerre P, Decullier E, Sève P.
• Quality of life in patients with uveitis: data from the ULISSE study (Uveitis: cLInical and medico-economic evaluation of a Standardised Strategy for the Etiological diagnosis).; Br J Ophthalmol. 2020 Jul 24:bjophthalmol-2020-315862. doi: 10.1136/bjophthalmol-2020-315862; Bertrand PJ, Jamilloux Y, Kodjikian L, Errera MH, Perard L, Pugnet G, Tieulie N, Andre M, Bielefeld P, Bron AM, Decullier E, Bin S, Seve P.

• Hydroxychloroquine levels in patients with systemic lupus erythematosus: whole blood is preferable but serum levels also detect non-adherence.      Blanchet B, Jallouli M, Allard M, Ghillani-Dalbin P, Galicier L, Aumaître O, Chasset F, Le Guern V, Lioté F, Smail A, Limal N, Perard L, Desmurs-Clavel H, Le Thi Huong D, Asli B, Kahn JE, Sailler L, Ackermann F, Papo T, Sacré K, Fain O, Stirnemann J, Cacoub P, Leroux G, Cohen-Bittan J, Sellam J, Mariette X, Goulvestre C, Hulot JS, Amoura Z, Vidal M, Piette JC; PLUS Group, Jourde-Chiche N, Costedoat-Chalumeau N.; Arthritis Res Ther. 2020 Sep 25;22(1):223.